No direct connection CR, just thought it would be of some interest to Solbec holders as example of FDA approval process . It seems to have a fairly safe profile , but from what I have read it has been approved on tumour reduction without proving increased survival time and with fairly weak data . I think it is positive for Coramsine , which has already demonstrated significant tumour reduction in some phase 1/2a patients .
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.